Michael J. Silverberg, PhD, MPH

People

Cabotegravir PrEP: Actionable Robust Evidence for Translation into Practice (CABARET)

This study will characterize adoption, quantify impact, and determine cost-effectiveness of long-acting injectable HIV preexposure prophylaxis (LAI PrEP) to inform implementation strategies. We will evaluate implementation and impact of LAI PrEP in geographically and racially diverse areas of the U.S. with high HIV incidence and will include members of 3 regions of Kaiser Permanente: Northern California, Mid-Atlantic, and Georgia. Specific Aims include: 1) characterizing adoption and clinical outcomes of LAI PrEP in clinical practice; 2) quantifying the impact of LAI PrEP on HIV incidence and drug resistance; and 3) determining the cost-effectiveness of LAI vs. oral PrEP. The expected outcome of this study is actionable evidence on the adoption and projected impact of LAI PrEP in the first years of its availability, informing long-term implementation strategies for PrEP scale-up in the U.S.
Investigator: Silverberg, Michael
Funder: National Institute of Allergy and Infectious Diseases

Cervical Cancer Screening After Age 65 in the Era of HPV Testing: Estimating Benefits and Harms of Screening Cessation and Continuation

Although cervical cancer screening has been successful in the United States, little is known about the optimal circumstances under which screening can safely end. This study will address this research gap by estimating cervical cancer screening benefits and harms after age 65 in a large group of women enrolled in two large integrated healthcare systems in California. Using data from 2 KP regions (KPNC, KPSC), this study aims to: 1) determine whether cervical cancer incidence and mortality in individuals over age 65 varies by historical clinical factors used in guidelines for ending cervical cancer screening; 2) estimate cervical cancer screening benefits and harms in individuals over age 65; and 3) use cost-effectiveness analyses to identify the optimal criteria for ending cervical cancer screening in women.
Investigator: Silverberg, Michael
Funder: National Cancer Institute

Assessing Syndemics of Cardiovascular Disease in People with and without HIV

Cardiovascular disease (CVD) is a large and growing public health problem, especially for people with HIV (PWH). Within Kaiser Permanente, we use a syndemic approach to investigate combinations of social and biological conditions that may act synergistically to increase risk for of CVD in PWH, with a focus on the understudied conditions of mental health, substance use, economic factors, social isolation, stigma/discrimination, trauma history, and healthcare access challenges. This study will use Kaiser Permanente's comprehensive electronic health record data, detailed Research Bank survey data, and stored serum to investigate the association of HIV status on Major Adverse Cardiovascular Events and preclinical biomarkers for cardiovascular disease. Study findings have potential to identify community- and health system-based CVD prevention interventions for vulnerable PWH.
Investigator: Silverberg, Michael
Funder: National Heart, Lung, and Blood Institute

Kaiser PrEP data

The purpose of this study is to initiate a 5-year collaboration between the Centers for Disease Control and Prevention (CDC) and 3 KP regions (KPNC, KPSC and KPMAS) to include PrEP prescription data and key demographics in the U.S. Department of Health and Human Service America's HIV Epidemic Analysis Dashboard (AHEAD). This data will be used by the CDC to enhance existing surveillance, evaluation, and research activities in support of the federal Ending the HIV Epidemic in the U.S. Initiative.
Investigator: Silverberg, Michael
Funder: Centers for Disease Control and Prevention

An Expanded National Cohort Study of Transgender People

The Study of Transition, Outcomes and Gender (STRONG) is an ongoing cohort study of transgender people enrolled in Kaiser Permanente (KP) integrated health care plans in Georgia (KPGA), Northern California (KPNC) and Southern California (KPSC), and includes 6,459 members for years 2006 through 2014. In this study, we add a new site at Kaiser Permanente Mid-Atlantic States (KPMAS) and extend cohort members and follow-up through 2022. We will study acute cardiovascular events in relation to gender affirming testosterone (HT), characterize mental health status of transgender people, and evaluate changes in clinical health indicators in relation to HT receipt.
Investigator: Silverberg, Michael
Funder: National Institute on Aging

(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV

Cancer is the leading cause of death among persons with HIV (PWH). Studies have found significant disparities in cancer therapy initiation and survival for PWH compared with the general population. This study will evaluate differences in cancer treatment by HIV status and measure the impact of HIV status and patient-related risk factors on the rates of adverse events and long-term comorbidity and mortality.
Investigator: Silverberg, Michael
Funder: National Cancer Institute

Comparison of Cross-Sex Hormone Therapies in Relation to Risks of Vascular Events

The risk of acute thrombotic events such as venous thromboembolism (VTE) and ischemic stroke in transgender women receiving hormone therapy was addressed in our longitudinal Study of Transition, Outcomes & Gender (STRONG), supported by the Patient-Centered Outcomes Research Institute. STRONG is a cohort of transgender people enrolled in Kaiser Permanente’s Georgia, Northern California, and Southern California regions. This project found increased risk of VTE and ischemic stroke among transwomen treated with estrogen; however, the development of practical recommendations for the management of transwomen will require a more formal pharmacoepidemiologic analysis evaluating comparative risks of different hormone formulations, routes of administration, and doses. These data are available, but the definitive analyses were not possible due to sparse treatment-specific strata. To address these limitations, with this supplement we will include additional subjects identified at existing STRONG sites through the end of 2018 and extend follow up through mid-2019.
Investigator: Silverberg, Michael
Funder: Patient-Centered Outcomes Research Institute

Mentoring Alcohol-Use Intervention Research in Health Care Settings

This research will examine the relationship of alcohol use and depression over time using data based in the electronic health record (EHR), in the context of health care. We will conduct secondary analysis of depression and hazardous drinking patterns in an HIV-positive patient alcohol intervention trial sample (n = 614). We will also examine use of EHR tools and other factors associated with reduction in hazardous drinking over time (e.g., use of patient portals and secure messaging) in order to develop additional EHR-assisted alcohol interventions.
Investigator: Satre, Derek; Silverberg, Michael
Funder: National Institute on Alcohol Abuse and Alcoholism

Comparison of Cross-Sex Hormone Therapies in Relation to Risks of Vascular Events

The risk of acute thrombotic events such as venous thromboembolism (VTE) and ischemic stroke in transgender women receiving hormone therapy was addressed in our longitudinal Study of Transition, Outcomes and Gender (STRONG). STRONG is a cohort of transgender people enrolled in Kaiser Permanente's Georgia, Northern California, and Southern California regions. This project found increased risk of VTE and ischemic stroke among transwomen treated with estrogen; however, the development of practical recommendations for the management of transwomen will require a more formal pharmaco-epidemiologic analysis evaluating comparative risks of different hormone formulations, routes of administration, and doses. These data are available, but the definitive analyses were not possible due to sparse treatment-specific strata. To address these limitations, we will include additional subjects identified at existing STRONG sites through the end of 2018 and extending follow up through mid-2019.
Investigator: Silverberg, Michael
Funder: Patient-Centered Outcomes Research Institute

Safety of Direct-Acting Antiviral Medications for Hepatitis C

This project will identify all patients who have a laboratory-confirmed diagnosis of Hepatitis C. The intervention group will be those who had a prescription filled for a new antiviral medication after October 10, 2014, and who were naive to treatment for Hep C prior to the prescription. The comparison group will be those who have not been treated for Hep C. Incidence of the following types of adverse events will be measured: acute or acute-on-chronic or uncertain cause liver failure (including liver transplant), acute kidney failure, myocardial infarction, liver cancer, multiple organ failure, stroke, and death. For liver failure in particular, a chart review will be conducted to validate the outcome. The initial analysis will use a Poisson model that includes exposure time (time to adverse event or censoring event). Other analytic methods may be employed to address channeling by indication.
Investigator: Silverberg, Michael
Funder: Patient-Centered Outcomes Research Institute

HIV Infection, Use of Tenofovir and Other Antiretrovirals, and Risk of Fatal and Non-Fatal Comorbidities: Cohort Study in Kaiser Permanente

Although the benefits of combination antiretroviral therapy (ART) for reducing HIV-related morbidity and mortality are well-recognized, toxicity from some ART may potentially contribute to excess age-related comorbidities. Certain antiretrovirals, including tenofovir, have known renal toxicity, but recent formulations may be associated with improved outcomes. Tenofovir-based ART is also increasingly used in high-risk HIV-uninfected individuals for HIV preexposure prophylaxis (PrEP), although the long-term health outcomes are unknown. The goal of this study is to characterize the incidence and predictors of key fatal and non-fatal comorbidities in HIV patients, and in demographically similar comparison groups of HIV-uninfected patients, including a general population sample, and HIV-uninfected individuals prescribed PrEP. This research will be conducted in approximately 39,000 HIV-infected and 390,000 HIV-uninfected subjects from Kaiser Permanente Northern California, Kaiser Permanente Southern California, and Kaiser Permanente of the Mid-Atlantic States.
Investigator: Silverberg, Michael
Funder: Gilead Sciences, Inc.

Safety of Direct Acting Antiviral Medications for Hepatitis C

This project will identify all patients who have a laboratory-confirmed diagnosis of Hepatitis C. The intervention group will be those who had a prescription filled for a new antiviral medication after October 10, 2014, and who were naive to treatment for Hep C prior to the prescription. The comparison group will be those who have not been treated for Hep C. Incidence of the following types of adverse events will be measured: acute or acute-on-chronic or uncertain cause liver failure (including liver transplant), acute kidney failure, myocardial infarction, liver cancer, multiple organ failure, stroke, and death. For liver failure in particular, a chart review will be conducted to validate the outcome. The initial analysis will use a Poisson model that includes exposure time (time to adverse event or censoring event). Other analytic methods may be employed to address channeling by indication.
Investigator: Silverberg, Michael
Funder: Patient-Centered Outcomes Research Institute

Safety of Direct-Acting Antiviral Medications for Hepatitis C

This study will investigate the safety of direct-acting antiviral medications in patients who have a laboratory-confirmed diagnosis of hepatitis C. The intervention group will be those who had a prescription filled for a new antiviral medication after October 10, 2014. The comparison group will be those who have not been treated for hepatitis C. Incidence of the following types of adverse events will be measured: acute or acute-on-chronic or uncertain-cause liver failure (including liver transplant), acute kidney failure, myocardial infarction, liver cancer, multiple organ failure, stroke, and death. For liver failure in particular, a chart review will be conducted to validate the outcome. Initial analysis will use a Poisson model that includes exposure time (time to adverse event or censoring event). Other analytic methods may be employed to address channeling by indication.
Investigator: Silverberg, Michael
Funder: Patient-Centered Outcomes Research Institute

Extension of the Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance (COMpAAAS)

With support from the National Institute on Alcohol Abuse and Alcoholism, the Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance (COMpAAAS) has analyzed data from patients in the Veterans Administration Cohort Study. This project seeks to extend this consortium to include Kaiser Permanente and the antiretroviral therapy cohort collaboration at the University of Bristol as new partners to increase sample diversity and representation of people living with HIV. The primary goals of the study are to evaluate the risk of alcohol and tobacco exposure on mortality, hospitalizations, comorbidities, and physiologic frailty for people living with HIV and matched HIV-uninfected controls. Each of the collaborating sites will share aims and study protocols, and will coordinate data management, statistical analysis, and reporting of results to increase sample size, include diverse populations, enhance comparability and generalizability, and maximize impact, as well as utilize resources efficiently.
Investigator: Satre, Derek; Silverberg, Michael
Funder: National Institute on Alcohol Abuse and Alcoholism

Optimizing Lung Cancer Treatment in HIV Infected Persons

Lung cancer is now a leading cause of death in HIV infected persons. Lung cancer survival is worse in HIV infected persons, in part due to uncertainty regarding the optimal treatment pathways for this group. In this project we will use data from several large, representative HIV cohorts to calibrate a well-validated, biologically-based simulation model of lung cancer (the Lung Cancer Policy Model) to determine the lung cancer treatments that offer the best life expectancy and quality-of-life for HIV infected lung cancer patients.
Investigator: Silverberg, Michael
Funder: National Cancer Institute

Effectiveness and safety of interferon-free treatment for hepatitis C virus (HCV) infection in a clinical practice setting

This a cohort study of KPNC patients initiating interferon-free treatment for HCV infection, with the following specific aims: 1) Determine the short- and long-term effectiveness of interferon-free treatment for HCV infection, 2) determine the safety of interferon-free treatment for HCV infection, and 3) compare the effectiveness and safety of 8- versus 12-week interferon-free treatment for HCV infection. Our results will guide clinical decision-making to maximize the effectiveness and safety of HCV treatment for KPNC patients.
Investigator: Silverberg, Michael
Funder: The Permanente Medical Group

Optimizing Cardiovascular Risk Prediction in HIV

The objective of this study is to develop methods to accurately predict cardiovascular disease (CVD) risk for HIV patients. CVD risk is increased for HIV patients, yet accurate methods for risk prediction remain unclear. We will evaluate the performance of the Framingham Risk Score (FRS) and the ACC/AHA risk prediction algorithm among HIV patients and generate new CVD risk prediction algorithms incorporating HIV and HIV-related factors to assess whether risk prediction can be improved for this population. The HIV-specific CVD risk prediction algorithms will be generated in collaboration with Framingham Heart Study investigators using an HIV clinical care cohort from the Partners HealthCare System and will be externally validated using the Kaiser Permanente Northern California (KPNC) HIV cohort. The ability to accurately risk-stratify HIV patients will ensure that the highest risk patients receive appropriate treatment and will directly impact long-term HIV care strategies.
Investigator: Silverberg, Michael
Funder: National Heart, Lung, and Blood Institute

HIV Status and Incidence and Outcomes of Heart Failure

Antiretroviral therapy (ART) has prolonged the lifespan of HIV-infected patients, resulting in a growing number of individuals aging with HIV infection. As this population ages, comorbidities, such as cardiovascular disease have increasingly contributed to excess morbidity and mortality. Unlike acute myocardial infarction, heart failure incidence is increasing in the general population, with associated serious morbidity and excess mortality, but has received less attention in the HIV population. Leveraging the Cardiovascular Research Network's Heart Failure consortium, our study goals are: 1) To characterize the association of HIV status with the incidence of heart failure; 2) Among HIV-infected patients, to evaluate the effect of ART use, CD4 and HIV viral replication on the incidence of heart failure; and 3) To examine the influence of HIV status on heart failure-related treatment patterns, hospitalizations and death among incident heart failure patients.
Investigator: Silverberg, Michael
Funder: National Heart, Lung, and Blood Institute

HPV Vaccine Impact Study

The California Emerging Infections Program will collaborate with the California Department of Health Services to develop a comprehensive plan to conduct systematic population-based cervical intraepithelial neoplasia surveillance and implement a pilot project in Alameda County. This population-based surveillance project aims to monitor the impact of the HPV vaccine on cervical cancer precursor lesions.
Investigator: Silverberg, Michael
Funder: Centers for Disease Control and Prevention

HIV Drug Resistance Mutation as Predictors of Clinical Outcome

In collaboration with KPNC clinicians and investigators, Stanford performs research investigations regarding the relationship of HIV resistance, antiretroviral therapy and clinical outcomes, including CD4 and HIV RNA response.
Investigator: Silverberg, Michael
Funder: Stanford University

Implementing Computerized Substance Use and Depression Screening and Evidence-Based Treatments in an HIV Primary Care Population

This proposal will develop and test the delivery of integrated, sustainable, evidence-based interventions to improve health outcomes of people living with HIV with substance use disorders (SUDs). The intervention will be delivered in advance of routine health care visits, and aims to systematize SUD screening aided by use of patient portals, within several large HIV clinics in KPNC. Outcomes of interest include ongoing substance use, linkage with primary-care-based SUD-services, antiretroviral therapy adherence and response, and comorbidities linked to both SU and HIV.
Investigator: Silverberg, Michael
Funder: National Institute on Drug Abuse

Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons

The overarching goal of this study is to formulate evidence-based recommendations about the preferred CD4 T-cell count at which to initiate antiretroviral therapy (ART), and the preferred initial ART regimen, that would minimize cancer incidence among HIV-infected persons.
Investigator: Silverberg, Michael
Funder: National Cancer Institute

Using Comparative Effectiveness Analyses to Optimize Cervical Cancer Screening

The overall goal of this study is to identify optimal cervical cancer screening strategies that minimize associated screening harms, while maximizing benefits. The approach will use decision analytic models and comparative effectiveness analyses to identify novel screening strategies that provide similar benefits and harms, resulting in a range of options for cervical cancer screening, which might vary by individual risk factors.
Investigator: Silverberg, Michael
Funder: National Cancer Institute

North America AIDS Cohorts Collaboration on Research and Design (NA-ACCORD)

The NA-ACCORD is a consortium of HIV cohorts across U.S. and Canada endeavoring to address major HIV-related clinical and epidemiologic questions that cannot be addressed through smaller studies. Dr. Silverberg is leading the HIV and Cancer research efforts in NA-ACCORD.
Investigator: Silverberg, Michael
Funder: National Institute of Allergy and Infectious Diseases

No results found matching criteria

Age group differences in substance use, social support, and physical and mental health concerns among people living with HIV two years after receiving primary care-based alcohol treatment

Author(s): Satre, Derek D; Sarovar, Varada; Leyden, Wendy A; Leibowitz, Amy S; Lam, Jennifer O; Hojilla, J Carlo; Davy-Mendez, Thibaut; Hare, Charles B; Silverberg, Michael J

Aging Ment Health. 2023 May;27(5):1011-1019. Epub 2022-06-29.

PubMed abstract

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies

Author(s): Trickey, Adam; Silverberg, Michael J; Sterne, Jonathan A C; et al.

Lancet HIV. 2023 May;10(5):e295-e307. Epub 2023-03-20.

PubMed abstract

Prevalence of Self-Inflicted Injuries Among Transgender and Gender Diverse Adolescents and Young Adults Compared to Their Peers: An Examination of Interaction with Mental Health Morbidity

Author(s): Pampati, Sanjana; Silverberg, Michael J; Goodman, Michael; et al.

Ann Epidemiol. 2023 May;81:40-46.e2. Epub 2023-03-11.

PubMed abstract

Provider- and Facility-Level Variation in Pre-Cancerous Cervical Biopsy Diagnoses

Author(s): Del Vecchio, Natalie J; Corley, Douglas A; Silverberg, Michael; et al.

J Low Genit Tract Dis. 2023 Apr 01;27(2):113-119. Epub 2023-01-17.

PubMed abstract

Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults

Author(s): Siira, Meron; Getahun, Darios; Silverberg, Michael J; Tangpricha, Vin; Goodman, Michael; Yeung, Howa

J Sex Med. 2023 Mar 31;20(4):568-572.

PubMed abstract

Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine

Author(s): Jetsupphasuk, Michael; Silverberg, Michael J; Eron, Joseph J; et al.

Am J Epidemiol. 2023 Mar 15.

PubMed abstract

Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout

Author(s): Lea, Alexandra N; Marafino, Ben J; Skarbinski, Jacek; Silverberg, Michael J; et al.

Clin Infect Dis. 2023 Mar 02.

PubMed abstract

Influenza Vaccination Uptake and Associated Factors Among Adults With and Without HIV in a Large, Integrated Health Care System

Author(s): Imp, Brandon M; Levine, Tory; Satre, Derek D; Skarbinski, Jacek; Luu, Mitchell N; Sterling, Stacy A; Silverberg, Michael J

Clin Infect Dis. 2023 Mar 01.

PubMed abstract

Effect of adopting the new race-free 2021 CKD-EPI eGFR creatinine equation on racial differences in kidney disease progression among people with HIV; an observational study

Author(s): Muiru, Anthony N; Silverberg, Michael J; Estrella, Michelle M; et al.

Clin Infect Dis. 2023 Feb 08;76(3):461-468.

PubMed abstract

Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings

Author(s): Chao, Chun R; Silverberg, Michael J; Corley, Douglas A; Wheeler, Cosette M; et al.

Cancer Med. 2023 Feb;12(3):3705-3717. Epub 2022-09-15.

PubMed abstract

The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum

Author(s): Lang, Raynell; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA),; et al.

AIDS. 2023 Feb 01;37(2):259-269. Epub 2022-11-10.

PubMed abstract

The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017

Author(s): Lang, Raynell; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research, Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA),; et al.

AIDS. 2023 Feb 01;37(2):287-298. Epub 2022-11-10.

PubMed abstract

Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US

Author(s): Zalla, Lauren C; Silverberg, Michael J; Edwards, Jessie K; et al.

JAMA. 2023 Jan 03;329(1):52-62.

PubMed abstract

Sexually Transmitted Infection Screening in Key Populations of Persons Living with HIV

Author(s): Hojilla, J Carlo; Sarovar, Varada; Lam, Jennifer O; Park, Ina U; Vincent, Wilson; Hare, C Bradley; Silverberg, Michael J; Satre, Derek D

AIDS Behav. 2023 Jan;27(1):96-105. Epub 2022-08-02.

PubMed abstract

Statins utilization in adults with HIV: The treatment gap and predictors of statin initiation

Author(s): Coburn, Sally B; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA,; et al.

J Acquir Immune Defic Syndr. 2022 12 15;91(5):469-478.

PubMed abstract

Negative Control Exposures: Causal effect Identifiability and Use in Probabilistic-Bias and Bayesian Analyses with Unmeasured Confounders

Author(s): Flanders, W D; Waller, L A; Zhang, Q; Getahun, D; Silverberg, M; Goodman, M

Epidemiology. 2022 Nov 01;33(6):832-839. Epub 2022-07-27.

PubMed abstract

Longitudinal HIV care outcomes by gender identity in the United States

Author(s): Lesko, Catherine R; Silverberg, Michael J; Poteat, Tonia C; et al.

AIDS. 2022 11 01;36(13):1841-1849. Epub 2022-07-21.

PubMed abstract

Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection

Author(s): Lang, Raynell; Silverberg, Michael J; Althoff, Keri N; et al.

J Am Heart Assoc. 2022 10 04;11(19):e026473. Epub 2022-09-21.

PubMed abstract

Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US

Author(s): Lang, Raynell; Silverberg, Michael J; Skarbinski, Jacek; Corona-Infectious-Virus Epidemiology Team (CIVETs) of the NA-ACORD of IeDEA,; et al.

JAMA Netw Open. 2022 10 03;5(10):e2236397. Epub 2022-10-03.

PubMed abstract

Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection

Author(s): Lam, Jennifer O; Ambrosy, Andrew P; Go, Alan S; Silverberg, Michael J; et al.

J Acquir Immune Defic Syndr. 2022 Oct 01;91(2):175-181.

PubMed abstract

Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care

Author(s): Davy-Mendez, Thibaut; Sterling, Stacy A; Weisner, Constance M; Silverberg, Michael J; Satre, Derek D; et al.

AIDS Behav. 2022 Sep 28.

PubMed abstract

Mortality for adults entering HIV care under universal early treatment compared to the general US population

Author(s): Edwards, Jessie K; Silverberg, Michael J; Eron, Joseph J; et al.

Clin Infect Dis. 2022 Sep 14;75(5):867-874.

PubMed abstract

Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America

Author(s): McGinnis, Kathleen A; Silverberg, Michael J; Veterans Aging Cohort Study,; et al.

Clin Infect Dis. 2022 Aug 25;75(2):297-304.

PubMed abstract

Toward Ending the HIV Epidemic: Temporal Trends and Disparities in Early ART Initiation and Early Viral Suppression Among People Newly Entering HIV Care in the United States, 2012-2018

Author(s): Li, Jun; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS,; et al.

Open Forum Infect Dis. 2022 Aug;9(8):ofac336. Epub 2022-07-22.

PubMed abstract

Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV

Author(s): Willis, Sarah J; Silverberg, Michael J; Marcus, Julia L; et al.

HIV Med. 2022 07;23(6):620-628. Epub 2021-12-23.

PubMed abstract

SARS-CoV-2 testing and positivity among persons with and without HIV in 6 United States cohorts

Author(s): Park, Lesley S; Silverberg, Michael J; Skarbinski, Jacek; Althoff, Keri N; et al.

J Acquir Immune Defic Syndr. 2022 07 01;90(3):249-255.

PubMed abstract

Sampling Validation Data to Achieve a Planned Precision of the Bias-Adjusted Estimate of Effect

Author(s): Collin, Lindsay J; MacLehose, Richard F; Ahern, Thomas P; Gradus, Jaimie L; Getahun, Darios; Silverberg, Michael J; Goodman, Michael; Lash, Timothy L

Am J Epidemiol. 2022 Jun 27;191(7):1290-1299.

PubMed abstract

CD4/CD8 Ratio and Cancer Risk among Adults with HIV

Author(s): Castilho, Jessica L; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA),; et al.

J Natl Cancer Inst. 2022 06 13;114(6):854-862.

PubMed abstract

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study

Author(s): Trickey, Adam; Silverberg, Michael J; Sterne, Jonathan A C; et al.

Lancet HIV. 2022 06;9(6):e404-e413.

PubMed abstract

Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States

Author(s): Coburn, Sally B; Silverberg, Michael J; Skarbinski, Jacek; Corona-Infectious-Virus Epidemiology Team (CIVETs) of the NA-ACCORD of IeDEA,; et al.

JAMA Netw Open. 2022 Jun 01;5(6):e2215934. Epub 2022-06-01.

PubMed abstract

Multimorbidity Burden and Incident Heart Failure Among People With and Without HIV: The HIV-HEART Study

Author(s): Mefford, Matthew T; Silverberg, Michael J; Leong, Thomas K; Hechter, Rulin C; Towner, William J; Go, Alan S; Horberg, Michael; Hu, Haihong; Harrison, Teresa N; Sung, Sue Hee; Reynolds, Kristi

Mayo Clin Proc Innov Qual Outcomes. 2022 Jun;6(3):218-227. Epub 2022-05-03.

PubMed abstract

Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV

Author(s): Kim, H Nina; Silverberg, Michael J; Kitahata, Mari M; et al.

J Acquir Immune Defic Syndr. 2022 04 01;89(4):396-404.

PubMed abstract

Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America

Author(s): Coelho, Lara E; Silverberg, Michael J; Rebeiro, Peter F; et al.

Lancet Reg Health Am. 2022 Apr;8. Epub 2022-01-05.

PubMed abstract

Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data from the STRONG Cohort

Author(s): Islam, Noreen; Silverberg, Michael J; Goodman, Michael; et al.

J Clin Endocrinol Metab. 2022 03 24;107(4):e1549-e1557.

PubMed abstract

Comparative Outcomes for Mature T and NK/T-cell Lymphomas in People with and without HIV and to AIDS-Defining Lymphomas

Author(s): Koh, Min Jung; Silverberg, Michael J; Jain, Salvia; et al.

Blood Adv. 2022 03 08;6(5):1420-1431.

PubMed abstract

The HIV preexposure prophylaxis (PrEP) continuum of care among transgender individuals in an integrated healthcare system

Author(s): Hojilla, J Carlo; Hurley, Leo B; Marcus, Julia L; Satre, Derek D; Silverberg, Michael J; Zaritsky, Eve F; Getahun, Darios; Goodman, Michael; Volk, Jonathan E

J Acquir Immune Defic Syndr. 2022 03 01;89(3):e30.

PubMed abstract

The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030

Author(s): Althoff, Keri N; Silverberg, Michael J; Kasaie, Parastu; et al.

AIDS. 2022 03 01;36(3):459-471.

PubMed abstract

Human Immunodeficiency Virus Infection and Variation in Heart Failure Risk by Age, Sex, and Ethnicity: The HIV HEART Study

Author(s): Go, Alan S; Lee, Keane K; Silverberg, Michael J; et al.

Mayo Clin Proc. 2022 03;97(3):465-479. Epub 2021-12-13.

PubMed abstract

Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study

Author(s): Lee, Jennifer S; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD),; et al.

Lancet HIV. 2022 03;9 Suppl 1:S2.

PubMed abstract

Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016

Author(s): Lam, Jennifer O; Lee, Catherine; Gilsanz, Paola; Hou, Craig E; Leyden, Wendy A; Satre, Derek D; Flamm, Jason A; Towner, William J; Horberg, Michael A; Silverberg, Michael J

AIDS. 2022 03 01;36(3):437-445.

PubMed abstract

Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care

Author(s): Lea, Alexandra N; Altschuler, Andrea; Leibowitz, Amy S; Levine-Hall, Tory; McNeely, Jennifer; Silverberg, Michael J; Satre, Derek D

Addict Sci Clin Pract. 2022 02 09;17(1):10. Epub 2022-02-09.

PubMed abstract

Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design

Author(s): Young, Jim; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA,; et al.

Pharmacoepidemiol Drug Saf. 2022 02;31(2):214-224. Epub 2021-11-23.

PubMed abstract

Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy

Author(s): Lu, Haidong; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research, Design of the International Epidemiologic Databases to Evaluate AIDS,; et al.

AIDS. 2022 02 01;36(2):277-286.

PubMed abstract

Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States

Author(s): Kasaie, Parastu; Silverberg, Michael J; Althoff, Keri N; et al.

Ann Epidemiol. 2022 01;65:46-55. Epub 2021-10-07.

PubMed abstract

Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD

Author(s): Qian, Yuhang; Silverberg, Michael J; Althoff, Keri N; et al.

J Acquir Immune Defic Syndr. 2022 01 01;89(1):9-18.

PubMed abstract

Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort

Author(s): Jefferson, Celeena; Silverberg, Michael J; Skarbinski, Jacek; NA-ACCORD Corona-Infectious-Virus Epidemiology Team (CIVET),; et al.

PLoS One. 2022;17(11):e0276742. Epub 2022-11-23.

PubMed abstract

COVID-19 infections post-vaccination by HIV status in the United States

Author(s): Coburn, Sally B; Silverberg, Michael; Skarbinski, Jacek; Corona-Infectious-Virus Epidemiology Team (CIVETs) of the NA-ACCORD of IeDEA,; et al.

medRxiv. 2021 Dec 05.

PubMed abstract

Cancer in people with and without hepatitis C virus infection: comparison of risk before and after introduction of direct-acting antivirals

Author(s): Lam, Jennifer O; Champsi, Jamila H; Silverberg, Michael J; et al.

Cancer Epidemiol Biomarkers Prev. 2021 12;30(12):2188-2196. Epub 2021-09-28.

PubMed abstract

Treatment for alcohol use disorder among persons with and without HIV in a clinical care setting in the United States

Author(s): Davy-Mendez, Thibaut; Sarovar, Varada; Levine-Hall, Tory; Lea, Alexandra N; Sterling, Stacy A; Chi, Felicia W; Palzes, Vanessa A; Bryant, Kendall J; Weisner, Constance M; Silverberg, Michael J; Satre, Derek D

Drug Alcohol Depend. 2021 12 01;229(Pt A):109110. Epub 2021-09-28.

PubMed abstract

Improved gonorrhea and chlamydia testing among men who have sex with men living with HIV through implementation of self-collected tests

Author(s): Park, Ina U; Reminick, Dominique; Schapiro, Jeffrey M; Hurley, Leo B; Hare, Charles Brad; Slome, Sally; Flamm, Jason A; Anderson, Alexandra; Silverberg, Michael J; Allerton, Michael W

Sex Transm Dis. 2021 11 01;48(11):e165-e167.

PubMed abstract

Human immunodeficiency virus infection and risks of morbidity and death in adults with incident heart failure

Author(s): Avula, Harshith R; Ambrosy, Andrew P; Silverberg, Michael J; Lee, Keane K; Go, Alan S; et al.

Eur Heart J Open. 2021 Nov;1(3):oeab040. Epub 2021-12-01.

PubMed abstract

Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada

Author(s): Lu, Haidong; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS,; et al.

Clin Infect Dis. 2021 10 05;73(7):e1408-e1414.

PubMed abstract

CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018

Author(s): Lee, Jennifer S; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD),; et al.

Clin Infect Dis. 2021 10 05;73(7):e2334-e2337.

PubMed abstract

Survey of Dermatologic Procedures in Transgender Adults

Author(s): Ragmanauskaite, Laura; Zhang, Qi; Kim, Jin; Getahun, Darios; Silverberg, Michael J; Goodman, Michael; Yeung, Howa

Dermatol Surg. 2021 10 01;47(10):1379-1383.

PubMed abstract

Risk of Hepatocellular Carcinoma with Hepatitis B Viremia among HIV/Hepatitis B Virus-Coinfected Persons in North America

Author(s): Kim, H Nina; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research, Design of IeDEA,; et al.

Hepatology. 2021 09;74(3):1190-1202. Epub 2021-06-22.

PubMed abstract

Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study

Author(s): Edwards, Jessie K; Silverberg, Michael J; Eron, Joseph J; et al.

Ann Intern Med. 2021 09;174(9):1197-1206. Epub 2021-07-06.

PubMed abstract

Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy

Author(s): Hashemi, Leila; Zhang, Qi; Getahun, Darios; Jasuja, Guneet K; McCracken, Courtney; Pisegna, Joseph; Roblin, Douglas; Silverberg, Michael J; Tangpricha, Vin; Vupputuri, Suma; Goodman, Michael

J Sex Med. 2021 09;18(9):1662-1675. Epub 2021-08-05.

PubMed abstract

Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy

Author(s): Hashemi, Leila; Zhang, Qi; Getahun, Darios; Jasuja, Guneet K; McCracken, Courtney; Pisegna, Joseph; Roblin, Douglas; Silverberg, Michael J; Tangpricha, Vin; Vupputuri, Suma; Goodman, Michael

J Sex Med. 2021 Sep 01;18(9):1662-1675.

PubMed abstract

Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years

Author(s): Davy-Mendez, Thibaut; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA); et al.

J Infect Dis. 2021 08 16;224(4):657-666. Epub 2020-12-26.

PubMed abstract

Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System

Author(s): Hojilla, J Carlo; Hurley, Leo B; Marcus, Julia L; Silverberg, Michael J; Skarbinski, Jacek; Satre, Derek D; Volk, Jonathan E

JAMA Netw Open. 2021 08 02;4(8):e2122692. Epub 2021-08-02.

PubMed abstract

Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015

Author(s): Davy-Mendez, Thibaut; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA,; et al.

AIDS. 2021 07 01;35(8):1229-1239.

PubMed abstract

Progression of Gender Dysphoria in Children and Adolescents: A Longitudinal Study

Author(s): Wagner, Stephanie; Panagiotakopoulos, Leonidas; Nash, Rebecca; Bradlyn, Andrew; Getahun, Darios; Lash, Timothy L; Roblin, Douglas; Silverberg, Michael J; Tangpricha, Vin; Vupputuri, Suma; Goodman, Michael

Pediatrics. 2021 07;148(1). Epub 2021-06-07.

PubMed abstract

Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic

Author(s): Riley, Elise D; Dilworth, Samantha E; Satre, Derek D; Silverberg, Michael J; Neilands, Torsten B; Mangurian, Christina; Weiser, Sheri D

JAMA Netw Open. 2021 07 01;4(7):e2117035. Epub 2021-07-01.

PubMed abstract

Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015

Author(s): Davy-Mendez, Thibaut; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design of IeDEA,; et al.

J Infect Dis. 2021 06 15;223(12):2113-2123.

PubMed abstract

Timing of Antiretroviral Therapy Initiation and Risk of Cancer among Persons Living with HIV

Author(s): Silverberg, Michael J; Neugebauer, Romain S; et al.

Clin Infect Dis. 2021 06 01;72(11):1900-1909.

PubMed abstract

Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America

Author(s): Coburn, Sally B; Silverberg, Michael J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to Evaluate AIDS,; et al.

J Acquir Immune Defic Syndr. 2021 05 01;87(1):663-670.

PubMed abstract

Changes in Size and Demographic Composition of Transgender and Gender Non-Binary Population Receiving Care at Integrated Health Systems

Author(s): Zhang, Qi; Silverberg, Michael J; Goodman, Michael; et al.

Endocr Pract. 2021 May;27(5):390-395. Epub 2020-12-15.

PubMed abstract

Comparison of dementia risk after age 50 between individuals with and without HIV infection

Author(s): Lam, Jennifer O; Hou, Craig E; Hojilla, J Carlo; Anderson, Alexandra N; Gilsanz, Paola; Alexeeff, Stacey E; Levine-Hall, Tory; Hood, Nicole; Lee, Catherine; Satre, Derek D; Silverberg, Michael J

AIDS. 2021 04 01;35(5):821-828.

PubMed abstract

An automated algorithm using free-text clinical notes to improve identification of transgender people

Author(s): Xie, Fagen; Silverberg, Michael J; Goodman, Michael; et al.

Inform Health Soc Care. 2021 Mar 02;46(1):18-28. Epub 2020-11-17.

PubMed abstract

Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone

Author(s): Braun, Hayley; Zhang, Qi; Getahun, Darios; Silverberg, Michael J; Tangpricha, Vin; Goodman, Michael; Yeung, Howa

JAMA Dermatol. 2021 03 01;157(3):344-346.

PubMed abstract

The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system

Author(s): Satre, Derek D; Sterling, Stacy A; Young-Wolff, Kelly C; Lam, Jennifer O; Alexeeff, Stacey; Weisner, Constance; Silverberg, Michael J; et al.

Drug Alcohol Depend. 2021 02 01;219:108481. Epub 2021-01-08.

PubMed abstract

HIV Stigma and Its Associations with Longitudinal Health Outcomes Among Persons Living with HIV with a History of Unhealthy Alcohol Use

Author(s): Hojilla JC; Santiago-Rodriguez EI; Sterling S; Williams EC; Leyden W; Hare CB; Silverberg MJ; Satre DD

AIDS Behav. 2021 Jan;25(1):215-224.

PubMed abstract

Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years

Author(s): Davy-Mendez T; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA; et al.

J Infect Dis. 2020 Dec 26.

PubMed abstract

Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco

Author(s): Hojilla JC; Marcus JL; Silverberg MJ; Hare CB; Herbers R; Hurley L; Satre DD; Volk JE

Clin Infect Dis. 2020 12 17;71(10):2710-2712.

PubMed abstract

Effect of Body Weight and Other Metabolic Factors on Risk of Non-Small Cell Lung Cancer among Veterans with HIV and a History of Smoking

Author(s): Garcia, Jose M; Kramer, Jennifer R; Richardson, Peter A; Ahmed, Sarah; Royse, Kathryn E; White, Donna L; Raychaudhury, Suchismita; Chang, Elaine; Hartman, Christine M; Silverberg, Michael J; Chiao, Elizabeth Y

Cancers (Basel). 2020 Dec 17;12(12). Epub 2020-12-17.

PubMed abstract

Self-reported tattoo prevalence and motivations in transgender adults: a cross-sectional survey

Author(s): Ragmanauskaite, Laura; Kim, Jin; Zhang, Qi; Luk, Kevin M; Getahun, Darios; Silverberg, Michael J; Goodman, Michael; Yeung, Howa

Dermatol Online J. 2020 Dec 15;26(12). Epub 2020-12-15.

PubMed abstract

Health System-Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically-Matched Participants With and Without HIV

Author(s): Silverberg, Michael J; Alexeeff, Stacey E; Lam, Jennifer O; Weisner, Constance M; Sterling, Stacy A; Satre, Derek D; et al.

Alcohol Clin Exp Res. 2020 12;44(12):2545-2554. Epub 2020-11-10.

PubMed abstract

Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study

Author(s): Satre, Derek D; Parthasarathy, Sujaya; Silverberg, Michael J; Horberg, Michael; Young-Wolff, Kelly C; Williams, Emily C; Volberding, Paul; Campbell, Cynthia I

BMC Health Serv Res. 2020 Nov 11;20(1):1030. Epub 2020-11-11.

PubMed abstract

Beyond the HIV Care Continuum and Viral Suppression: Broadening the Scope of Quality Metrics for Total HIV Patient Care

Author(s): Horberg, Michael A; Certa, Julia M; Rubenstein, Kevin B; Hurley, Leo B; Satre, Derek D; Kadlecik, Peter M; Silverberg, Michael J

AIDS Patient Care STDS. 2020 11;34(11):461-469.

PubMed abstract

Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy

Author(s): Antun, Ana; Silverberg, Michael J; Goodman, Michael; et al.

J Endocr Soc. 2020 Nov 01;4(11):bvaa119. Epub 2020-08-25.

PubMed abstract

Oral leukoplakia and risk of progression to oral cancer: A population-based cohort study

Author(s): Chaturvedi AK; Udaltsova N; Engels EA; Katzel JA; Yanik EL; Katki HA; Lingen MW; Silverberg MJ

J Natl Cancer Inst. 2020 10 01;112(10):1047-1054.

PubMed abstract

Suicide Attempts Among a Cohort of Transgender and Gender Diverse People

Author(s): Mak, Josephine; Hunkeler, Enid M; Silverberg, Michael J; Goodman, Michael; et al.

Am J Prev Med. 2020 10;59(4):570-577. Epub 2020-08-12.

PubMed abstract

Response to Brandt, Bednarz-Knoll, Kleinheinz et al

Author(s): Chaturvedi AK; Udaltsova N; Engels EA; Katzel JA; Yanik EL; Katki HA; Lingen MW; Silverberg MJ

J Natl Cancer Inst. 2020 09 01;112(9):970-971.

PubMed abstract

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens

Author(s): Rhee, Soo-Yon; Clutter, Dana; Hare, C Bradley; Tchakoute, Christophe T; Sainani, Kristin; Fessel, W Jeffrey; Hurley, Leo; Slome, Sally; Pinsky, Benjamin A; Silverberg, Michael J; Shafer, Robert W

2020 Sep;7(9):ofaa316. Epub 2020-08-06.

PubMed abstract

Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system

Author(s): Lam JO; Levine-Hall T; Hood N; Alexeeff SE; Horberg MA; Young-Wolff KC; Sterling SA; Williams A; Weisner C; Satre DD; Silverberg MJ

Drug Alcohol Depend. 2020 08 01;213:108128. Epub 2020-06-18.

PubMed abstract

Adaptive Validation Design: A Bayesian Approach to Validation Substudy Design With Prospective Data Collection

Author(s): Collin LJ; MacLehose RF; Ahern TP; Nash R; Getahun D; Roblin D; Silverberg MJ; Goodman M; Lash TL

Epidemiology. 2020 07;31(4):509-516.

PubMed abstract

Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers

Author(s): Holt, Hunter K; Kulasingam, Shalini; Sanstead, Erinn C; Alarid-Escudero, Fernando; Smith-McCune, Karen; Gregorich, Steven E; Silverberg, Michael J; Huchko, Megan J; Kuppermann, Miriam; Sawaya, George F

2020 Jul-Dec;5(2):2381468320952409. Epub 2020-08-19.

PubMed abstract

Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women

Author(s): Silverberg MJ; Leyden WA; Lam JO; Chao CR; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF

Vaccine. 2020 06 15;38(29):4520-4523. Epub 2020-05-20.

PubMed abstract

Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data

Author(s): Satre DD; Sarovar V; Leyden W; Hare CB; Catz SL; Bryant KJ; Williams EC; Hojilla JC; Horberg MA; Silverberg MJ

AIDS Behav. 2020 Jun;24(6):1784-1792.

PubMed abstract

Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016

Author(s): Marcus JL; Leyden WA; Alexeeff SE; Anderson AN; Hechter RC; Hu H; Lam JO; Towner WJ; Yuan Q; Horberg MA; Silverberg MJ

JAMA Netw Open. 2020 06 01;3(6):e207954. Epub 2020-06-01.

PubMed abstract

Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV

Author(s): Hojilla JC; Marcus J; Volk JE; Leyden W; Hare CB; Hechter RC; Edelman EJ; Silverberg M; Satre DD

Sex Transm Infect. 2020 05;96(3):184-188. Epub 2019-08-23.

PubMed abstract

Addressing Problems With Alcohol and Other Substances Among Older Adults During the COVID-19 Pandemic

Author(s): Satre DD; Hirschtritt ME; Silverberg MJ; Sterling SA

Am J Geriatr Psychiatry. 2020 Apr 22.

PubMed abstract

Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada

Author(s): Hernández-Ramírez RU; Neugebauer RS; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; et al.

Clin Infect Dis. 2020 03 03;70(6):1176-1185.

PubMed abstract

Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis

Author(s): Poteat T; Silverberg MJ; Althoff KN; et al.

Clin Infect Dis. 2020 03 03;70(6):1131-1138.

PubMed abstract

Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium

Author(s): Barlow WE; Corley DA; Silverberg MJ; Tiro JA; et al.

J Natl Cancer Inst. 2020 03 01;112(3):238-246.

PubMed abstract

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017

Author(s): Seo S; Silverberg MJ; Marcus JL; et al.

Clin Gastroenterol Hepatol. 2020 02;18(2):511-513. Epub 2019-04-19.

PubMed abstract

Cervical cancer risk in women living with HIV across four continents: A multicohort study

Author(s): Rohner E; Silverberg MJ; Bohlius J; et al.

Int J Cancer. 2020 02 01;146(3):601-609. Epub 2019-06-19.

PubMed abstract

Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017

Author(s): Marcus JL; Lam JO; Quesenberry CP; Silverberg MJ; et al.

Open Forum Infect Dis. 2020 Feb;7(2):ofaa044. Epub 2020-02-05.

PubMed abstract

LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL

Author(s): Althoff KN; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA; et al.

Am J Epidemiol. 2019 12 31;188(12):2097-2109.

PubMed abstract

Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States

Author(s): Saadeh K; Park I; Gargano JW; Whitney E; Querec TD; Hurley L; Silverberg M

Vaccine. 2019 Oct 11.

PubMed abstract

Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial

Author(s): Satre DD; Lam JO; Weisner CM; Sterling SA; Silverberg MJ; et al.

J Gen Intern Med. 2019 10;34(10):2054-2061. Epub 2019-06-11.

PubMed abstract

Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study

Author(s): Marcus JL; Hurley LB; Krakower DS; Alexeeff S; Silverberg MJ; Volk JE

Lancet HIV. 2019 10;6(10):e688-e695. Epub 2019-07-05.

PubMed abstract

Mental and Physical Quality of Life by Age Groups in People Living With HIV

Author(s): Jang HJ; Satre DD; Leyden W; Leibowitz A; Silverberg MJ

J Assoc Nurses AIDS Care. 2019 Sep-Oct;30(5):500-510.

PubMed abstract

Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients

Author(s): Lo Re V; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of IeDEA; et al.

J Acquir Immune Defic Syndr. 2019 09 01;82(1):71-80.

PubMed abstract

Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial

Author(s): Satre DD; Weisner CM; Silverberg MJ; et al.

Contemp Clin Trials. 2019 09;84:105833. Epub 2019-08-22.

PubMed abstract

Short-term outcomes for lung cancer resection surgery in HIV infection

Author(s): Sigel KM; Silverberg MJ; Crothers K; et al.

AIDS. 2019 07 01;33(8):1353-1360.

PubMed abstract

Early outcomes of a high-resolution anoscopy-based anal cancer screening program among people with HIV enrolled in an integrated healthcare system

Author(s): Barnell GM; Merchant M; Lam JO; Silverberg MJ

J Acquir Immune Defic Syndr. 2019 07 01;81(3):292-299.

PubMed abstract

Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis

Author(s): Sawaya GF; Sanstead E; Alarid-Escudero F; Smith-McCune K; Gregorich SE; Silverberg MJ; Leyden W; Huchko MJ; Kuppermann M; Kulasingam S

JAMA Intern Med. 2019 07 01;179(7):867-878.

PubMed abstract

Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting

Author(s): Lam JO; Hurley LB; Udaltsova N; Alexeeff SE; Klein DB; Corley DA; Silverberg MJ

J Acquir Immune Defic Syndr. 2019 07 01;81(3):284-291.

PubMed abstract

Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.

Author(s): Lam, Jennifer O JO; Hurley, Leo B LB; Chamberland, Scott S; Champsi, Jamila H JH; Gittleman, Laura C LC; Korn, Daniel G DG; Lai, Jennifer B JB; Quesenberry, Charles P CP; Ready, Joanna J; Saxena, Varun V; Seo, Suk I SI; Witt, David J DJ; Silverberg, Michael J MJ; Marcus, Julia L JL

International journal of STD & AIDS. 2019 Jun ;30(7):689-695. Epub 2019-05-02.

PubMed abstract

Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California

Author(s): Marcus JL; Hurley LB; Dentoni-Lasofsky D; Ellis CG; Silverberg MJ; Slome S; Snowden JM; Volk JE

AIDS Care. 2019 05;31(5):536-544. Epub 2018-10-10.

PubMed abstract

Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data

Author(s): Althoff KN; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design; et al.

Ann Epidemiol. 2019 05;33:54-63. Epub 2019-03-04.

PubMed abstract

Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study

Author(s): Hernández-Ramírez RU; Neugebauer RS; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; et al.

Lancet HIV. 2019 04;6(4):e240-e249. Epub 2019-02-27.

PubMed abstract

National and International Dimensions of Human Immunodeficiency Virus-1 Sequence Clusters in a Northern California Clinical Cohort

Author(s): Rhee SY; Magalis BR; Hurley L; Silverberg MJ; Marcus JL; Slome S; Kosakovsky Pond SL; Shafer RW

Open Forum Infect Dis. 2019 Apr;6(4):ofz135. Epub 2019-03-14.

PubMed abstract

Adverse childhood experiences, mental health, substance use, and HIV-related outcomes among persons with HIV

Author(s): Young-Wolff KC; Sarovar V; Sterling SA; Leibowitz A; McCaw B; Hare CB; Silverberg MJ; Satre DD

AIDS Care. 2019 Mar 19:1-9.

PubMed abstract

Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort

Author(s): Kamineni A; Silverberg MJ; Corley DA; PROSPR consortium; et al.

Int J Cancer. 2019 03 15;144(6):1460-1473. Epub 2018-12-20.

PubMed abstract

Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates

Author(s): Bradley H; Silverberg MJ; Rosenberg ES; et al.

Ann Epidemiol. 2019 03;31:3-7. Epub 2018-11-22.

PubMed abstract

One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States

Author(s): Desir FA; Silverberg M; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Region of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium; et al.

Clin Infect Dis. 2019 02 15;68(5):795-802.

PubMed abstract

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies

Author(s): Althoff KN; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design; et al.

Lancet HIV. 2019 02;6(2):e93-e104. Epub 2019-01-22.

PubMed abstract

Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals

Author(s): Marcus JL; Zaroff J; Go AS; Quesenberry CP; Lo JC; Silverberg MJ; et al.

HIV Med. 2019 01;20(1):19-26. Epub 2018-09-04.

PubMed abstract

Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients

Author(s): Lam JO; Barnell GM; Merchant M; Ellis CG; Silverberg MJ

HIV Med. 2018 11;19(10):716-723. Epub 2018-08-06.

PubMed abstract

Impact of Alternative Encounter Types on HIV Viral Suppression Rates in an Integrated Health System

Author(s): Horberg MA; Blank JG; Rubenstein KB; Certa JM; Hurley LB; Kadlecik PM; Klein DB; Silverberg MJ

AIDS Patient Care STDS. 2018 11;32(11):425-431.

PubMed abstract

Reduced cancer survival among adults with HIV and an AIDS-defining illnesses despite no difference in cancer stage at diagnosis

Author(s): Grover S; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design; et al.

J Acquir Immune Defic Syndr. 2018 12 01;79(4):421-429.

PubMed abstract

Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system

Author(s): Horberg MA; Oakes AH; Hurley LB; Towner WJ; Chao CR; Silverberg MJ; Chantra JQ; Ellis CG; Quesenberry CP

HIV Clin Trials. 2018 10;19(5):177-187. Epub 2018-10-27.

PubMed abstract

Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study

Author(s): Silverberg MJ; Leyden WA; Leibowitz A; Hare CB; Jang HJ; Sterling S; Catz SL; Parthasarathy S; Horberg MA; Satre DD

Addict Behav. 2018 09;84:110-117. Epub 2018-03-31.

PubMed abstract

Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men

Author(s): Burger EA; Dyer MA; Sy S; Palefsky JM; de Pokomandy A; Coutlee F; Silverberg MJ; Kim JJ

J Acquir Immune Defic Syndr. 2018 09 01;79(1):10-19.

PubMed abstract

Agreement between medical records and self-reports: Implications for transgender health research

Author(s): Gerth J; Hunkeler EM; Silverberg MJ; Goodman M; et al.

Rev Endocr Metab Disord. 2018 09;19(3):263-269.

PubMed abstract

Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study

Author(s): Getahun D; Hunkeler E; Silverberg MJ; Goodman M; et al.

Ann Intern Med. 2018 08 21;169(4):205-213. Epub 2018-07-10.

PubMed abstract

Cutaneous Melanoma Risk among People with HIV in the United States and Canada

Author(s): Yanik EL; Neugebauer RS; Silverberg MJ; Dubrow R; et al.

J Acquir Immune Defic Syndr. 2018 08 15;78(5):499-504.

PubMed abstract

Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

Author(s): Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF

Lancet Child Adolesc Health. 2018 Oct;2(10):707-714. Epub 2018-08-08.

PubMed abstract

Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population

Author(s): Marcus JL; Lam JO; Quesenberry CP; Silverberg MJ; et al.

Public Health Rep. 2018 Jul/Aug;133(4):452-460. Epub 2018-05-11.

PubMed abstract

Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ ≥ 500: a simulation study

Author(s): Kong CY; Sigel K; Criss SD; Sheehan DF; Triplette M; Silverberg MJ; Henschke CI; Justice A; Braithwaite RS; Wisnivesky J; Crothers K

AIDS. 2018 06 19;32(10):1333-1342.

PubMed abstract

Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV

Author(s): Elion RA; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of IeDEA; et al.

J Acquir Immune Defic Syndr. 2018 05 01;78(1):62-72.

PubMed abstract

Mental Health of Transgender and Gender Nonconforming Youth Compared With Their Peers

Author(s): Becerra-Culqui TA; Hunkeler EM; Silverberg MJ; Goodman M; et al.

Pediatrics. 2018 05;141(5). Epub 2018-04-16.

PubMed abstract

Recent Intrauterine device use and the risk of precancerous cervical lesions and cervical cancer

Author(s): Averbach S; Silverberg MJ; Leyden W; Smith-McCune K; Raine-Bennett T; Sawaya GF

Contraception. 2018 Apr 16.

PubMed abstract

Multimorbidity Among Persons Living with HIV in the U.S

Author(s): Wong C; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

Clin Infect Dis. 2018 04 03;66(8):1230-1238.

PubMed abstract

Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals

Author(s): Owen-Smith AA; Hunkeler E; Silverberg MJ; Goodman M; et al.

J Sex Med. 2018 Apr;15(4):591-600. Epub 2018-02-17.

PubMed abstract

Cancer burden attributable to cigarette smoking among HIV-infected people in North America

Author(s): Altekruse SF; Silverberg MJ; Engels EA; et al.

AIDS. 2018 02 20;32(4):513-521.

PubMed abstract

Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia

Author(s): Silverberg MJ; Leyden WA; Chi A; Gregorich S; Huchko MJ; Kulasingam S; Kuppermann M; Seto A; Smith-McCune KK; Sawaya GF

Obstet Gynecol. 2018 Jan;131(1):47-55.

PubMed abstract

Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people

Author(s): Quinn VP; Hunkeler E; Silverberg MJ; Goodman M; et al.

BMJ Open. 2017 12 27;7(12):e018121. Epub 2017-12-27.

PubMed abstract

Redefining HIV Preexposure Prophylaxis Failures

Author(s): Marcus JL; Hurley LB; Nguyen DP; Silverberg MJ; Volk JE

Clin Infect Dis. 2017 10 30;65(10):1768-1769.

PubMed abstract

Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load

Author(s): Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ

JAMA Dermatol. 2017 Sep 01;153(9):892-896.

PubMed abstract

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population

Author(s): Drozd DR; Silverberg MJ; Crane HM; et al.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576.

PubMed abstract

A Flow-Based Model of the HIV Care Continuum in the United States

Author(s): Gonsalves GS; Silverberg MJ; Kaplan EH; et al.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):548-553.

PubMed abstract

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America

Author(s): Engels EA; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; et al.

Clin Infect Dis. 2017 Aug 15;65(4):636-643.

PubMed abstract

Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada

Author(s): Dubrow R; Neugebauer RS; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; et al.

J Acquir Immune Defic Syndr. 2017 Aug 01;75(4):382-390.

PubMed abstract

Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men: a Qualitative Study

Author(s): Storholm ED; Volk JE; Marcus JL; Silverberg MJ; Satre DD

Prev Sci. 2017 Aug;18(6):737-747.

PubMed abstract

Cohort study of cancer risk among insured transgender people

Author(s): Silverberg MJ; Hunkeler E; Goodman M; et al.

Ann Epidemiol. 2017 08;27(8):499-501. Epub 2017-07-22.

PubMed abstract

Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing

Author(s): Clutter DS; Silverberg MJ; Shafer RW; et al.

J Infect Dis. 2017 Aug 01;216(3):387-391.

PubMed abstract

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors

Author(s): Muzaale AD; Silverberg MJ; Segev DL; et al.

Am J Transplant. 2017 Jul;17(7):1823-1832. Epub 2017-05-12.

PubMed abstract

Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals

Author(s): Marcus JL; Leyden WA; Chao CR; Horberg MA; Klein DB; Quesenberry CP; Towner WJ; Silverberg MJ

AIDS. 2017 Apr 24;31(7):989-993.

PubMed abstract

HIV Infection, Immune Suppression and Age at Diagnosis of Non-AIDS-Defining Cancers

Author(s): Shiels MS; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA); et al.

Clin Infect Dis. 2017 02 15;64(4):468-475.

PubMed abstract

First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013

Author(s): Wong C; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

Clin Infect Dis. 2017 02 15;64(4):459-467.

PubMed abstract

Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system

Author(s): Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP

Am J Obstet Gynecol. 2017 Feb;216(2):151.e1-151.e9. Epub 2016-10-14.

PubMed abstract

Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation

Author(s): Marcus JL; Hurley LB; Hare CB; Nguyen DP; Phengrasamy T; Silverberg MJ; Stoltey JE; Volk JE

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546.

PubMed abstract

Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics

Author(s): Satre DD; Altschuler A; Parthasarathy S; Silverberg MJ; Volberding P; Campbell CI

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):e76-e82.

PubMed abstract

First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013

Author(s): Wong C; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

Clin Infect Dis. 2016 Dec 10.

PubMed abstract

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras

Author(s): Klein MB; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA; et al.

Clin Infect Dis. 2016 Nov 01;63(9):1160-1167. Epub 2016-08-09.

PubMed abstract

Racial and Ethnic Differences in Substance Use Diagnoses, Comorbid Psychiatric Disorders, and Treatment Initiation among HIV-Positive and HIV-Negative Women in an Integrated Health Plan

Author(s): Storholm ED; Silverberg MJ; Satre DD

J Psychoactive Drugs. 2016 Nov-Dec;48(5):377-383. Epub 2016-10-21.

PubMed abstract

Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System

Author(s): Marcus JL; Hurley LB; Hare CB; Silverberg MJ; Volk JE

Am J Public Health. 2016 10;106(10):e2-3.

PubMed abstract

Higher Time-updated Body Mass Index: Association with Improved CD4+ Cell Recovery on HIV Treatment

Author(s): Koethe JR; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

J Acquir Immune Defic Syndr. 2016 Oct 01;73(2):197-204.

PubMed abstract

Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System

Author(s): Marcus JL; Baxter R; Leyden WA; Muthulingam D; Yee A; Horberg MA; Klein DB; Towner WJ; Chao CR; Quesenberry CP; Silverberg MJ

AIDS Patient Care STDS. 2016 Oct;30(10):463-470.

PubMed abstract

Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care

Author(s): Marcus JL; Chao CR; Leyden WA; Xu L; Quesenberry CP; Klein DB; Towner WJ; Horberg MA; Silverberg MJ

J Acquir Immune Defic Syndr. 2016 Sep 01;73(1):39-46.

PubMed abstract

Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California

Author(s): Satre DD; Parthasarathy S; Altschuler A; Silverberg MJ; Storholm E; Campbell CI

Am J Public Health. 2016 Jul;106(7):1211-3. Epub 2016-04-14.

PubMed abstract

Response to Therapy in Antiretroviral Therapy-Na෥ Patients with Isolated Nonnucleoside Reverse-Transcriptase Inhibitor-Associated Transmitted Drug Resistance

Author(s): Clutter DS; Fessel WJ; Rhee SY; Hurley LB; Klein DB; Ioannidis JP; Silverberg MJ; Shafer RW

J Acquir Immune Defic Syndr. 2016 Jun 01;72(2):171-6.

PubMed abstract

Use of abacavir and risk of cardiovascular disease among HIV-infected individuals

Author(s): Marcus JL; Neugebauer RS; Leyden WA; Chao CR; Xu L; Quesenberry CP; Klein DB; Towner WJ; Horberg MA; Silverberg MJ

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):413-9.

PubMed abstract

Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis

Author(s): Park LS; Hernández-Ramírez RU; Silverberg MJ; Crothers K; Dubrow R

AIDS. 2016 Jan;30(2):273-91.

PubMed abstract

Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

Author(s): Koethe JR; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

AIDS Res Hum Retroviruses. 2016 Jan;32(1):50-8. Epub 2015-09-09.

PubMed abstract

Predictive value of prostate specific antigen in a European HIV-positive cohort: does one size fit all?

Author(s): Shepherd L; Silverberg M; EuroSIDA in EuroCOORD; et al.

Antivir Ther (Lond). 2016;21(6):529-534. Epub 2016-01-29.

PubMed abstract

A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts

Author(s): Althoff KN; Sierra-Madero J; North American Aids Cohort Collaboration on Research and Design (NA-ACCORD) and Caribbean, Central and South America Network for Hiv Epidemiology (CCASAnet); et al.

J Int AIDS Soc. 2016;19(1):20707. Epub 2016-04-04.

PubMed abstract

Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America

Author(s): Rebeiro PF; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design; et al.

Am J Epidemiol. 2015 Dec 1;182(11):952-60. Epub 2015-11-17.

PubMed abstract

The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System

Author(s): Horberg MA; Silverberg MJ; et al.

AIDS Patient Care STDS. 2015 Nov;29(11):582-90.

PubMed abstract

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study

Author(s): Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; et al.

Ann Intern Med. 2015 Oct 6;163(7):507-18.

PubMed abstract

Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010

Author(s): Koethe JR; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

HIV Med. 2015 Oct;16(9):572-7. Epub 2015-05-11.

PubMed abstract

Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival

Author(s): Chao C; Xu L; Silverberg MJ; Martínez-Maza O; Chen LH; Castor B; Abrams DI; Zha HD; Haque R; Said J

AIDS. 2015 Sep 24;29(15):1943-51.

PubMed abstract

Leukoplakia, oral cavity cancer risk, and cancer survival in the U.S. elderly

Author(s): Yanik EL; Katki HA; Silverberg MJ; Manos MM; Engels EA; Chaturvedi AK

Cancer Prev Res (Phila). 2015 Sep;8(9):857-63. Epub 2015-07-09.

PubMed abstract

Survival Among HIV-Infected and HIV-Uninfected Individuals with Common Non-AIDS-Defining Cancers

Author(s): Marcus JL; Chao C; Leyden WA; Xu L; Yu J; Horberg MA; Klein D; Towner WJ; Quesenberry CP; Abrams DI; Silverberg MJ

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1167-73. Epub 2015-02-24.

PubMed abstract

Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status

Author(s): Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ

AIDS Patient Care STDS. 2015 Jul;29(7):370-8. Epub 2015-05-18.

PubMed abstract

Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV

Author(s): Saberi P; Catz SL; Leyden WA; Stewart C; Ralston JD; Horberg MA; Grothaus L; Silverberg MJ

AIDS Behav. 2015 Jun;19 Suppl 2:177-85.

PubMed abstract

Contribution of Demographic and Behavioral Factors on the Changing Incidence Rates of Oropharyngeal and Oral Cavity Cancers in Northern California

Author(s): Katzel JA; Merchant M; Chaturvedi AK; Silverberg MJ

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):978-84. Epub 2015-05-08.

PubMed abstract

Declining Relative Risk for Myocardial Infarction Among HIV-Positive Compared With HIV-Negative Individuals With Access to Care

Author(s): Klein DB; Leyden WA; Xu L; Chao CR; Horberg MA; Towner WJ; Hurley LB; Marcus JL; Quesenberry CP; Silverberg MJ

Clin Infect Dis. 2015 Apr 15;60(8):1278-80. Epub 2015-01-16.

PubMed abstract

The Impact of Age on Retention in Care and Viral Suppression

Author(s): Yehia BR; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):413-9.

PubMed abstract

End Stage Renal Disease Among HIV-Infected Adults in North America

Author(s): Abraham AG; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA); et al.

Clin Infect Dis. 2015 Mar 15;60(6):941-9. Epub 2014-11-18.

PubMed abstract

A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection

Author(s): Chao C; Silverberg MJ; Xu L; Chen LH; Castor B; Martínez-Maza O; Abrams DI; Zha HD; Haque R; Said J

Clin Cancer Res. 2015 Mar 15;21(6):1429-37. Epub 2015-01-14.

PubMed abstract

Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia

Author(s): Park IU; Wojtal N; Silverberg MJ; Bauer HM; Hurley LB; Manos MM

PLoS ONE. 2015;10(3):e0118938. Epub 2015-03-20.

PubMed abstract

Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals

Author(s): Beachler DC; Abraham AG; Silverberg MJ; Jing Y; Fakhry C; Gill MJ; Dubrow R; Kitahata MM; Klein MB; Burchell AN; Korthuis PT; Moore RD; D'Souza G; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA

Oral Oncol. 2014 Dec;50(12):1169-76. Epub 2014-10-06.

PubMed abstract

HIV infection and incidence of ischemic stroke

Author(s): Marcus JL; Leyden WA; Chao CR; Chow FC; Horberg MA; Hurley LB; Klein DB; Quesenberry CP; Towner WJ; Silverberg MJ

AIDS. 2014 Aug 24;28(13):1911-9.

PubMed abstract

Prostate Cancer Incidence and Prostate-Specific Antigen Testing Among HIV-Positive and HIV-Negative Men

Author(s): Marcus JL; Chao CR; Leyden WA; Xu L; Klein DB; Horberg MA; Towner WJ; Quesenberry CP; Abrams DI; Van Den Eeden SK; Silverberg MJ

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):495-502.

PubMed abstract

Non-AIDS-Defining Malignancies in the HIV-Infected Population

Author(s): Wang CC; Silverberg MJ; Abrams DI

Curr Infect Dis Rep. 2014 Jun;16(6):406.

PubMed abstract

Disparities in the quality of HIV care when using US Department of Health and Human Services Indicators

Author(s): Althoff KN; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

Clin Infect Dis. 2014 Apr;58(8):1185-9. Epub 2014-01-23.

PubMed abstract

Immunodeficiency and Risk of Myocardial Infarction Among HIV-Positive Individuals With Access to Care

Author(s): Silverberg MJ; Leyden WA; Xu L; Horberg MA; Chao CR; Towner WJ; Hurley LB; Quesenberry CP; Klein DB

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):160-6.

PubMed abstract

Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk

Author(s): Borges AH; Dubrow R; Silverberg MJ

Curr Opin HIV AIDS. 2014 Jan;9(1):34-40.

PubMed abstract

Strong agreement of nationally recommended retention measures from the institute of medicine and department of health and human services

Author(s): Rebeiro PF; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD); et al.

PLoS ONE. 2014;9(11):e111772. Epub 2014-11-06.

PubMed abstract

Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA

Author(s): Shepherd L; Silverberg M; EuroSIDA in Eurocoord; et al.

J Int AIDS Soc. 2014;17(4 Suppl 3):19510. Epub 2014-11-02.

PubMed abstract

Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients

Author(s): Delorenze GN; Horberg MA; Silverberg MJ; Tsai A; Quesenberry CP; Baxter R

Epidemiol Infect. 2013 Nov;141(11):2392-402. Epub 2013-02-18.

PubMed abstract

Missed Office Visits and Risk of Mortality Among HIV-Infected Subjects in a Large Healthcare System in the United States

Author(s): Horberg MA; Hurley LB; Silverberg MJ; Klein DB; Quesenberry CP; Mugavero MJ

AIDS Patient Care STDS. 2013 Aug;27(8):442-9. Epub 2013 Jul 19.

PubMed abstract

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

Author(s): Borges AH; Silverberg MJ; SILCAAT Study Groups; et al.

AIDS. 2013 Jun 1;27(9):1433-41.

PubMed abstract

Use of web-based shared medical records among patients with HIV

Author(s): Ralston JD; Silverberg MJ; Grothaus L; Leyden WA; Ross T; Stewart C; Carzasty S; Horberg M; Catz SL

Am J Manag Care. 2013 Apr;19(4):e114-24. Epub 2013-04-01.

PubMed abstract

Invasive cervical cancer risk among HIV-infected women: A North American multi-cohort collaboration prospective study

Author(s): Abraham AG; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of IeDEA; et al.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):405-13.

PubMed abstract

HIV Infection Status, Immunodeficiency, and the Incidence of Non-Melanoma Skin Cancer

Author(s): Silverberg MJ; Leyden W; Warton EM; Quesenberry CP Jr; Engels EA; Asgari MM

J Natl Cancer Inst. 2013 Mar 6;105(5):350-60. Epub 2013 Jan 4.

PubMed abstract

The Epidemiology of Herpes Zoster in Patients with Newly Diagnosed Cancer

Author(s): Habel LA; Ray GT; Silverberg MJ; Horberg MA; Yawn BP; Castillo AL; Quesenberry CP Jr; Li Y; Sadier P; Tran TN

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):82-90. Epub 2012 Nov 1.

PubMed abstract

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons

Author(s): Chao C; Leyden WA; Xu L; Horberg MA; Klein D; Towner WJ; Quesenberry CP Jr; Abrams DI; Silverberg MJ

AIDS. 2012 Nov 13;26(17):2223-31.

PubMed abstract

Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell lymphoma

Author(s): Chao C; Silverberg MJ; Martinez-Maza O; Chi M; Abrams DI; Haque R; Zha HD; McGuire M; Xu L; Said J

Clin Cancer Res. 2012 Sep 1;18(17):4702-12. Epub 2012 Jun 18.

PubMed abstract

HIV infection, aging, and immune function: implications for cancer risk and prevention

Author(s): Dubrow R; Silverberg MJ; Park LS; Crothers K; Justice AC

Curr Opin Oncol. 2012 Sep;24(5):506-16.

PubMed abstract

The Effect of HIV Infection, Immunodeficiency and Antiretroviral Therapy on the Risk of Hepatic Dysfunction

Author(s): Towner WJ; Xu L; Leyden WA; Horberg MA; Chao CR; Tang B; Klein DB; Hurley LB; Quesenberry CP Jr; Silverberg MJ

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):321-7.

PubMed abstract

Determination of Optimized Multidisciplinary Care Team for Maximal Antiretroviral Therapy Adherence

Author(s): Horberg MA; Bartemeier Hurley L; James Towner W; Allerton MW; Ting-Ting Tang B; Catz SL; Silverberg MJ; Quesenberry CP

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):183-90.

PubMed abstract

Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

Author(s): Silverberg MJ; the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA; et al.

Clin Infect Dis. 2012 Apr;54(7):1026-34. Epub 2012 Jan 30.

PubMed abstract

Influence of provider experience on antiretroviral adherence and viral suppression

Author(s): Horberg MA; Hurley LB; Towner WJ; Allerton MW; Tang BT; Catz SL; Silverberg MJ; Quesenberry CP

HIV AIDS (Auckl). 2012;4:125-33. Epub 2012 Aug 15.

PubMed abstract

Prescription Long-term Opioid Use in HIV-infected Patients

Author(s): Silverberg MJ; Ray GT; Saunders K; Rutter CM; Campbell CI; Merrill JO; Sullivan MD; Von Korff M; Weisner C; Banta-Green CJ

Clin J Pain. 2012 Jan;28(1):39-46.

PubMed abstract

HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer

Author(s): Silverberg MJ; Chao C; Leyden WA; Xu L; Horberg MA; Klein D; Towner WJ; Dubrow R; Quesenberry CP Jr; Neugebauer RS; Abrams DI

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9. Epub 2011 Nov 22.

PubMed abstract

Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america

Author(s): Abraham AG; Silverberg M; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; et al.

Am J Epidemiol. 2011 Sep 15;174(6):727-35. Epub 2011 Aug 3.

PubMed abstract

Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening

Author(s): Sterling TR; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA); et al.

J Infect Dis. 2011 Sep 15;204(6):893-901.

PubMed abstract

HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons

Author(s): Chao C; Xu L; Abrams DI; Towner WJ; Horberg MA; Leyden WA; Silverberg MJ

AIDS. 2011 Sep 10;25(14):1771-7.

PubMed abstract

Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus

Author(s): Saberi P; Ranatunga DK; Quesenberry CP; Silverberg MJ

Pharmacotherapy. 2011 Mar;31(3):253-61.

PubMed abstract

HIV quality performance measures in a large integrated health care system

Author(s): Horberg M; Quesenberry C; Silverberg M; Johnson M; et al.

AIDS Patient Care STDS. 2011 Jan;25(1):21-8.

PubMed abstract

Age and gender trends in long-term opioid analgesic use for noncancer pain

Author(s): Campbell CI; Weisner C; Leresche L; Ray GT; Saunders K; Sullivan MD; Banta-Green CJ; Merrill JO; Silverberg MJ; Boudreau D; Satre DD; Von Korff M

Am J Public Health. 2010 Dec;100(12):2541-7. Epub 2010 Aug 19.

PubMed abstract

Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy

Author(s): Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M

AIDS. 2010 Jul 17;24(11):1765-70.

PubMed abstract

Late presentation for human immunodeficiency virus care in the United States and Canada

Author(s): Althoff KN; Silverberg MJ; Moore RD; et al.

Clin Infect Dis. 2010 Jun 1;50(11):1512-20.

PubMed abstract

Opioid prescriptions for chronic pain and overdose: a cohort study

Author(s): Dunn KM; Saunders KW; Rutter CM; Banta-Green CJ; Merrill JO; Sullivan MD; Weisner CM; Silverberg MJ; Campbell CI; Psaty BM; Von Korff M

Ann Intern Med. 2010 Jan 19;152(2):85-92.

PubMed abstract

Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California

Author(s): Horberg MA; Ranatunga DK; Quesenberry CP; Klein DB; Silverberg MJ

Sex Transm Dis. 2010 Jan;37(1):53-8.

PubMed abstract

CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?

Author(s): Althoff KN; Silverberg MJ; for the North American AIDS Cohort Collaboration on Research and Design; et al.

AIDS Res Ther. 2010 Dec 15;7:45.

PubMed abstract

Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients

Author(s): Horberg M; Tang B; Towner W; Silverberg M; Bersoff-Matcha S; Hurley L; Chang J; Blank J; Quesenberry C Jr; Klein D

J Acquir Immune Defic Syndr. 2010 Jan 1;53(1):62-9.

PubMed abstract

Trends in long-term opioid therapy for chronic non-cancer pain

Author(s): Boudreau D; Von Korff M; Rutter CM; Saunders K; Ray GT; Sullivan MD; Campbell CI; Merrill JO; Silverberg MJ; Banta-Green C; Weisner C

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1166-75.

PubMed abstract

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America

Author(s): Deeks SG; Silverberg MJ; Moore RD; et al.

Clin Infect Dis. 2009 Nov 15;49(10):1582-90.

PubMed abstract

HIV infection and the risk of cancers with and without a known infectious cause

Author(s): Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP Jr; Towner WJ; Abrams DI

AIDS. 2009 Nov 13;23(17):2337-45.

PubMed abstract

Trends in long-term opioid therapy for noncancer pain among persons with a history of depression

Author(s): Braden JB; Sullivan MD; Ray GT; Saunders K; Merrill J; Silverberg MJ; Rutter CM; Weisner C; Banta-Green C; Campbell C; Von Korff M

Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):564-70. Epub 2009 Aug 27.

PubMed abstract

Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders

Author(s): Weisner CM; Campbell CI; Ray GT; Saunders K; Merrill JO; Banta-Green C; Sullivan MD; Silverberg MJ; Mertens JR; Boudreau D; Von Korff M

Pain. 2009 Oct;145(3):287-93. Epub 2009 Jul 5.

PubMed abstract

Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care

Author(s): Silverberg MJ; Leyden W; Quesenberry CP Jr; Horberg MA

J Gen Intern Med. 2009 Sep;24(9):1065-72. Epub 2009 Jul 16.

PubMed abstract

Increased rates of appendicitis in HIV-infected men: 1991-2005

Author(s): Klein DB; Hurley LB; Horberg MA; Silverberg MJ; Follansbee SE; Flamm JA; Green GM

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):139-40.

PubMed abstract

Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy

Author(s): Silverberg MJ; Jacobson LP; French AL; Witt MD; Gange SJ

J Pain Symptom Manage. 2009 Aug;38(2):197-207. Epub 2009 Mar 28.

PubMed abstract

Effect of early versus deferred antiretroviral therapy for HIV on survival

Author(s): Kitahata MM; Silverberg MJ; NA-ACCORD Investigators; et al.

N Engl J Med. 2009 Apr 30;360(18):1815-26. Epub 2009 Apr 1.

PubMed abstract

Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection

Author(s): Silverberg MJ; Leyden W; Hurley L; Go AS; Quesenberry CP Jr; Klein D; Horberg MA

Ann Intern Med. 2009 Mar 3;150(5):301-13.

PubMed abstract

Smoking enhances risk for new external genital warts in men

Author(s): Wiley DJ; Elashoff D; Masongsong EV; Harper DM; Gylys KH; Silverberg MJ; Cook RL; Johnson-Hill LM

Int J Environ Res Public Health. 2009 Mar;6(3):1215-34. Epub 2009 Mar 20.

PubMed abstract

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

Author(s): Silverberg MJ; Abrams D

Curr Opin HIV AIDS. 2009 Jan;4(1):42-51.

PubMed abstract

Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naive patients

Author(s): Horberg M; Klein D; Hurley L; Silverberg M; Towner W; Antoniskis D; Kovach D; Mogyoros M; Blake W; Dobrinich R; Dodge W

HIV Clin Trials. 2008 Nov-Dec;9(6):367-74.

PubMed abstract

De facto long-term opioid therapy for noncancer pain

Author(s): Korff MV; Saunders K; Thomas Ray G; Boudreau D; Campbell C; Merrill J; Sullivan MD; Rutter CM; Silverberg MJ; Banta-Green C; Weisner C

Clin J Pain. 2008 Jul-Aug;24(6):521-7.

PubMed abstract

Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens

Author(s): Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C

AIDS Patient Care STDS. 2008 Apr;22(4):301-12.

PubMed abstract

Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients

Author(s): Horberg MA; Silverberg MJ; Quesenberry CP; Kovach DA; et al.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):384-90.

PubMed abstract

Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort study

Author(s): Ostrow DG; Silverberg MJ; Cook RL; Chmiel JS; Johnson L; Li X; Jacobson LP; multicenter AIDS cohort study

AIDS Behav. 2008 Jan;12(1):127-38. Epub 2007 Apr 5.

PubMed abstract

AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era

Author(s): Silverberg MJ; Abrams DI

Curr Opin Oncol. 2007 Sep;19(5):446-51.

PubMed abstract

Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy

Author(s): Horberg MA; Hurley LB; Silverberg MJ; Kinsman CJ; Quesenberry CP

J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):531-9.

PubMed abstract

Older age and the response to and tolerability of antiretroviral therapy

Author(s): Silverberg MJ; Leyden W; Horberg MA; DeLorenze GN; Klein D; Quesenberry CP Jr

Arch Intern Med. 2007 Apr 9;167(7):684-91.

PubMed abstract

Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women

Author(s): Silverberg MJ; Schneider MF; Silver B; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine AM; Viscidi RP

Clin Vaccine Immunol. 2006 Apr;13(4):511-9.

PubMed abstract